The impact of prodigiosin on laryngeal microbial structure
Prodigiosin, a secondary metabolite exhibiting broad-spectrum antibacterial and antitumor properties, has demonstrated potential in modulating microbial communities. However, its effects on the laryngeal microbiota remains largely unknown.